U.K. faces shortage of top ADHD medications, driving patients towards medical cannabis clinics
A scarcity of stimulant-based medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in the U.K. has triggered a surge in patients turning to medical cannabis as an alternative for relief. The rise in individuals seeking medical cannabis highlights the growing demand for alternative treatments amidst the medication shortage.










